Lung Cancer Screening Market Analysis, Region & Country Revenue Share, & Forecast Till 2027
November 7, 2022 ⚊ 1 Min read ⚊ Views 75 ⚊ HEALTH
The global Lung Cancer Screening Market is forecasted to reach USD 4,215.5 Million by 2027, according to a new report by Reports and Data. The Lung Cancer Screening Market is observing demand attributed to the rising incidence of lung cancer. It may occur due to various reasons, including smoking, genetic, and exposure to toxic gases. The American Cancer Society projects over 228,000 lung cancer cases in the year 2020, with the occurrence of the disease being higher in men than women. It is a significant cause of death in both US men and women dying due to cancer.
The rise in the number of people suffering from non-small cell lung cancer is one of the major factors driving the global market growth. The risk factors such as air pollution, cigarette smoking, passive smoking, and occupational exposure are increasing the incidence of the disease globally. One of the major drivers of the disease is a strong drug pipeline and recent drug approvals.
